SCHEMBL7158554

SCHEMBL7158554

CCOC(=O)Cn1c(C)cnc(NCCc2ccccn2)c1=O

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2 P00734 20/20 0.63
PRSS1 P07477 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7364554 0.90 F2 (0.57) F2PRSS1
SCHEMBL7159962 0.87 F2 (0.70) F2PRSS1
SCHEMBL5474623 0.87 F2 (0.52) F2PRSS1
SCHEMBL5474694 0.86 F2 (0.64) F2PRSS1
SCHEMBL5479394 0.85 F2 (0.50) F2PRSS1
SCHEMBL5475081 0.82 KDM4E (0.47) F2PRSS1
SCHEMBL6957416 0.79 F2 (0.70) F2PRSS1
SCHEMBL3238207 0.79 F2 (0.64) F2PRSS1
SCHEMBL7151089 0.77 F2 (0.71) F2PRSS1
SCHEMBL7159467 0.77 F2 (0.73) F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534510-B2 Anticoagulants MERCK & CO., INC. 2003-03-18 US disclosed
US-20020006923-A1 Thrombin inhibitors MERCK & CO., INC. 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006923-A1 Thrombin inhibitors F2, F11, F12 F2 1/4885PRSS1 168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.